Organization · Venture Studio
Rambam AG
Rambam AG is a venture studio based in Zug, Switzerland, focused on breakthrough drug discovery and development. It collaborates with US and European venture companies to support early-stage biotech firms.
Overview
What Rambam AG does
What Rambam AG is
Rambam AG is a venture studio based in Zug, Switzerland, focused on breakthrough drug discovery and development. It collaborates with US and European venture companies to support early-stage biotech firms.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 27, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Rambam AG elsewhere
Open the official website or a supported primary organization account.
Capability profile
Rambam AG as a funder
Investment thesis
Rambam AG focuses on breakthrough drug discovery and development by investing in early-stage biotech companies, leveraging technology consulting to enhance venture funding and program design.
Focus narrative
Rambam AG invests primarily in early-stage biotech companies, providing seed and Series A capital. The organization emphasizes low attrition rates and focuses on high-value therapeutic areas, including immunology, oncology, central nervous system disorders, and infectious diseases. By utilizing artificial intelligence and computer-aided drug design, Rambam enhances its operational efficiency and investment outcomes.
Value beyond capital
Rambam AG adds value to its portfolio companies through strategic investment, technology consulting, and a structured approach to drug development, ensuring that startups receive the necessary support to advance their projects effectively.
Focus and fit
- Stages
- Seed · Series A
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Rambam AG has co-funded over 20 programs and companies in collaboration with partners such as OrbiMed and BGV, although specific portfolio companies or case studies were not detailed.
Capability profile
Rambam AG as a program host
Program thesis
Rambam AG aims to revolutionize drug discovery and development by investing in and supporting early-stage biotech ventures. The organization emphasizes the use of AI and computer-aided design to improve outcomes in therapeutic areas.
Focus narrative
The primary focus of Rambam AG is on early-stage biotech ventures, particularly in high-value therapeutic areas such as immunology, oncology, CNS disorders, and infectious diseases. The organization aims to support companies from their inception to early clinical candidates within a two-year period, emphasizing low attrition rates and effective use of AI in drug design.
Value and support
Founders working with Rambam AG benefit from strategic investment, access to a network of industry experts, and support in navigating the complexities of drug development. The venture studio provides both seed and series A capital, along with guidance in program design and execution.
Format and cadence
- Typical duration
- 104 weeks
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Sectors
- Biotech & Life Sciences
- Regions
- Europe · Global
Common questions
What to know about Rambam AG
Upseed classifies Rambam AG under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.